| 000 | 01316 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512005810.0 | ||
| 264 | 0 | _c19891017 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0896-8411 | ||
| 024 | 7 |
_a10.1016/0896-8411(89)90116-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChain, B M | |
| 245 | 0 | 0 |
_aAntigen processing: current issues, exceptional cases (Thy 1 alloantigen, MHC class-II-restricted cytolytic T cells), and implications for vaccine development. _h[electronic resource] |
| 260 |
_bJournal of autoimmunity _cJun 1989 |
||
| 300 |
_a45-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
| 650 | 0 | 4 | _aAntigens |
| 650 | 0 | 4 | _aAntigens, Surface |
| 650 | 0 | 4 | _aBiological Transport, Active |
| 650 | 0 | 4 | _aHistocompatibility Antigens Class II |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aThy-1 Antigens |
| 650 | 0 | 4 |
_aVaccines _xisolation & purification |
| 700 | 1 | _aMitchison, N A | |
| 700 | 1 | _aMitchison, T J | |
| 700 | 1 | _aDavies, D H | |
| 700 | 1 | _aMarcinkiewicz, J | |
| 773 | 0 |
_tJournal of autoimmunity _gvol. 2 Suppl _gp. 45-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0896-8411(89)90116-9 _zAvailable from publisher's website |
| 999 |
_c2576534 _d2576534 |
||